- Retraction Note
- Open Access
Retraction Note to: MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway
Journal of Hematology & Oncology volume 13, Article number: 142 (2020)
Retraction Note to: Journal of Hematology & Oncology (2017) 10:125 https://doi.org/10.1186/s13045-017-0493-0
In accordance with the guidelines published by COPE, the authors have retracted this article  because of significant concerns regarding a number of Figures presented in this work. In Fig. 3C and 3D there are duplications in the NC and NC-LV groups in the H460 cells, NC-LV, OE-miR-330-3p-LV and anti-miR-330-3p-LV groups in the H1975 cells. In Fig. 7D, the H1975/NC-LV Vec image has been duplicated from the H460/NC image in Fig. 3C. There are multiple duplications throughout Fig. 6, and there are duplications in Fig. 9D (OE-miR-330-3p-LV and OE-miR-330-3p-LV + U0126 groups in the H460 cells, OE-miR-330-3p-LV group in the H1975 cells). The data reported in this article are therefore unreliable.
All authors agree to this retraction.
Wei C, Wu G, Cai Q, et al. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway. J Hematol Oncol. 2017;10:125. https://doi.org/10.1186/s13045-017-0493-0.
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Wei, CH., Wu, G., Cai, Q. et al. Retraction Note to: MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway. J Hematol Oncol 13, 142 (2020). https://doi.org/10.1186/s13045-020-00969-0